G. Ornati

1.4k total citations
22 papers, 1.2k citations indexed

About

G. Ornati is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Ornati has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Ornati's work include Estrogen and related hormone effects (15 papers), Steroid Chemistry and Biochemistry (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). G. Ornati is often cited by papers focused on Estrogen and related hormone effects (15 papers), Steroid Chemistry and Biochemistry (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). G. Ornati collaborates with scholars based in Italy, United Kingdom and Norway. G. Ornati's co-authors include E. Di Salle, D. Giudici, G. Briatico, Per Eystein Lønning, T. Zaccheo, Mitch Dowsett, Nicholas King, Gun Anker, Jürgen Geisler and R. Charles Coombes and has published in prestigious journals such as Annals of the New York Academy of Sciences, Nephrology Dialysis Transplantation and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

G. Ornati

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Ornati Italy 15 941 407 294 265 209 22 1.2k
Luciana F. Macedo United States 19 579 0.6× 490 1.2× 443 1.5× 254 1.0× 99 0.5× 26 1.0k
Ben P. Haynes United Kingdom 20 1.1k 1.1× 634 1.6× 305 1.0× 509 1.9× 187 0.9× 33 1.5k
Venkatesh Handratta United States 12 412 0.4× 190 0.5× 435 1.5× 151 0.6× 180 0.9× 14 930
Michael Draper United States 5 941 1.0× 484 1.2× 368 1.3× 124 0.5× 543 2.6× 8 1.5k
Ellen R. Rowley United States 10 705 0.7× 254 0.6× 292 1.0× 78 0.3× 254 1.2× 10 1.0k
Alice E. Boucher United States 13 403 0.4× 288 0.7× 142 0.5× 167 0.6× 231 1.1× 24 799
Diana C. Márquez‐Garbán United States 16 496 0.5× 574 1.4× 463 1.6× 158 0.6× 69 0.3× 34 1.2k
Joan S. Lewis United States 9 400 0.4× 243 0.6× 338 1.1× 124 0.5× 55 0.3× 9 683
Surojeet Sengupta United States 18 289 0.3× 283 0.7× 437 1.5× 142 0.5× 57 0.3× 33 864
Tadas S. Vasaitis United States 19 384 0.4× 86 0.2× 525 1.8× 152 0.6× 307 1.5× 21 1.1k

Countries citing papers authored by G. Ornati

Since Specialization
Citations

This map shows the geographic impact of G. Ornati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ornati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ornati more than expected).

Fields of papers citing papers by G. Ornati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ornati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ornati. The network helps show where G. Ornati may publish in the future.

Co-authorship network of co-authors of G. Ornati

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ornati. A scholar is included among the top collaborators of G. Ornati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ornati. G. Ornati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salle, E. Di, D. Giudici, Antonella Radice, et al.. (1998). PNU 157706, a novel dual type I and II5α-reductase inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. 64(3-4). 179–186. 34 indexed citations
2.
Paridaens, Robert, José Thomas, J. Wildiers, et al.. (1998). Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study. Anti-Cancer Drugs. 9(8). 675–683. 36 indexed citations
3.
Geisler, Jürgen, Nicholas King, Gun Anker, et al.. (1998). In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.. PubMed. 4(9). 2089–93. 271 indexed citations
4.
Salle, E. Di, G. Briatico, D. Giudici, G. Ornati, & Achille Panzeri. (1994). Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073). The Journal of Steroid Biochemistry and Molecular Biology. 48(2-3). 241–248. 28 indexed citations
5.
Salle, E. Di, G. Briatico, D. Giudici, et al.. (1994). Novel aromatase and 5α-reductase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 49(4-6). 289–294. 47 indexed citations
6.
Salle, E. Di, et al.. (1993). Hormonal effects of turosteride, a 5α-reductase inhibitor, in the rat. The Journal of Steroid Biochemistry and Molecular Biology. 46(5). 549–555. 28 indexed citations
7.
Salle, E. Di, G. Briatico, D. Giudici, et al.. (1992). 17β-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5α-reductase. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 765–768. 13 indexed citations
8.
Salle, E. Di, G. Ornati, D. Giudici, et al.. (1992). Exemestane (FCE 24304), A new steroidal aromatase inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 137–143. 75 indexed citations
9.
Evans, T.R. Jeffry, E. Di Salle, G. Ornati, et al.. (1992). Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.. PubMed. 52(21). 5933–9. 129 indexed citations
10.
Zaccheo, T., D. Giudici, G. Ornati, Achille Panzeri, & E. Di Salle. (1991). Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours. European Journal of Cancer and Clinical Oncology. 27(9). 1145–1150. 30 indexed citations
11.
Panzeri, Achille, G. Ornati, E. Di Salle, & Paolo Lombardi. (1990). Synthesis and Biochemical Evaluation of the Novel Steroid Androsta-4,6,8(9)-Triene-3,17-Dione. Journal of enzyme inhibition. 4(2). 121–129. 3 indexed citations
12.
Salle, E. Di, T. Zaccheo, & G. Ornati. (1990). Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat. Journal of Steroid Biochemistry. 36(3). 203–206. 52 indexed citations
13.
Salle, E. Di, D. Giudici, G. Briatico, & G. Ornati. (1990). Novel Irreversible Aromatase Inhibitors. Annals of the New York Academy of Sciences. 595(1). 357–367. 45 indexed citations
14.
Salle, E. Di, D. Giudici, G. Ornati, et al.. (1990). 4-aminoandrostenedione derivatives: A novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 369–374. 34 indexed citations
15.
Salle, E. Di, G. Briatico, D. Giudici, G. Ornati, & T. Zaccheo. (1989). Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489. Journal of Steroid Biochemistry. 34(1-6). 431–434. 18 indexed citations
16.
Giudici, D., G. Ornati, G. Briatico, et al.. (1988). 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitor. Journal of Steroid Biochemistry. 30(1-6). 391–394. 122 indexed citations
17.
Salle, E. Di, D. Giudici, G. Ornati, G. Briatico, & Paolo Lombardi. (1987). Endocrine properties of 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304), a new irreversible aromatase inhibitor. Journal of Steroid Biochemistry. 28. 146–146. 9 indexed citations
18.
Salle, E. Di, et al.. (1986). Irreversible aromatase inhibition by 4-aminoandrosta-4,6-diene-3,17-dione (FCE 24210). Journal of Steroid Biochemistry. 25. 134–134. 3 indexed citations
19.
Giudici, D., T. Zaccheo, G. Ornati, & E. Di Salle. (1983). 434 Antitumor activity of fce 21336, a new prolactin lowering drug, on experimental hormone-responsive tumors. Journal of Steroid Biochemistry. 19. 145–145. 5 indexed citations
20.
Formelli, Franca, T. Zaccheo, E. Di Salle, G. Ornati, & Aurelio Di Marco. (1983). Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats. European Journal of Cancer and Clinical Oncology. 19(11). 1545–1551. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciana F. Macedo Breakdown of academic impact, for papers by Ben P. Haynes Breakdown of academic impact, for papers by Venkatesh Handratta Breakdown of academic impact, for papers by Michael Draper Breakdown of academic impact, for papers by Ellen R. Rowley Breakdown of academic impact, for papers by Alice E. Boucher Breakdown of academic impact, for papers by Diana C. Márquez‐Garbán Breakdown of academic impact, for papers by Joan S. Lewis Breakdown of academic impact, for papers by Surojeet Sengupta Breakdown of academic impact, for papers by Tadas S. Vasaitis
Rankless by CCL
2026